203 top medical experts on Immunoblastic Large-Cell Lymphoma across 15 countries and 11 U.S. states, including 62 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Immunoblastic Large-Cell Lymphoma: Malignant lymphoma characterized by the presence of immunoblasts with uniformly round-to-oval nuclei, one or more prominent nucleoli, and abundant cytoplasm. This class may be subdivided into plasmacytoid and clear-cell types based on cytoplasmic characteristics. A third category, pleomorphous, may be analogous to some of the peripheral T-cell lymphomas (lymphoma, T-cell, peripheral) recorded in both the United States and Japan.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Non-Hodgkin Lymphoma (4,309).
  4. Clinical Trials ClinicalTrials.gov : at least 123 including 8 Active, 83 Completed, 4 Recruiting
  5. Synonyms: Diffuse Immunoblastic Lymphosarcoma,  Immunoblastoma,  Large-Cell Immunoblastic Lymphoma,  Immunoblastic Sarcoma


  

        

                    


    Computing Expert Listing ...

);